Compare Quest Diagnostics Inc (DGX) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Public Storage — how do they compare? Quest Diagnostics Inc trades at $230.72 (market cap $25.48B), while Public Storage trades at $285.55 (market cap $53.35B). The key difference: Public Storage is far larger — about 2.1× Quest Diagnostics Inc's market cap, and Public Storage pays the higher dividend (4.2%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Public Storage for 130 Days on average.
| DGX | PSA | |
|---|---|---|
Market Cap | $25.48B | $53.35B |
Volume | 941,866 | 1,176,034 |
Sector | Health | Real Estate |
52-Week High | $247.45 | $330.47 |
52-Week Low | $173.49 | $258.44 |
Typical Hold Time | 56 Days | 130 Days |
Enterprise Value | $31.23B | $67.62B |
Dividend Yield | 1.49% | 4.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $227.00, down 0.64% on the day, with the stock showing strong fundamental performance including three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.04B in 2025. Technical indicators signal bearish momentum with the current price near key support at $226, while the company maintains solid profitability with 9.19% net income margin and 14.35% ROE. Recent developments include positive clinical study results and a new partnership with Apple Health app for lab testing integration.
The investment outlook remains positive with analyst consensus target of $250 representing 10% upside potential, though Medicare reimbursement cuts pose near-term headwinds. Growth drivers include advanced diagnostics expansion and consumer testing demand, balanced against technical weakness and regulatory uncertainty. The stock offers value with reasonable P/E of 24.1 and consistent dividend payments.
Public Storage (PSA) trades at $281.99, down 1.35% on the day, with a bearish technical signal and mixed sentiment. The stock exhibits strong profitability with a 41.8% net income margin and consistent earnings beats, but faces headwinds from negative net cash flow trends. Recent developments include the completion of the Public Storage Canada acquisition and a $400 million senior notes offering in the Canadian market, signaling expansion efforts.
PSA presents a cautious outlook with a consensus price target of $328.33 implying upside, yet technical indicators and cash flow concerns weigh. Investment opportunities lie in its high margins and dividend yield, while risks include operational execution amid interest rate sensitivity and competitive pressures in the REIT sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
